Athanasios Kotsakis相关文献与解析，生知库

Katerina Tsilingiri #, Anna Chalari #, Georgia Christopoulou, Alexandra Voutsina, Pantelis Constantoulakis, Κonstantinos Potaris, Ioannis Vamvakaris, Dora Hatzidaki, Georgina Zachou, Giannis Vatsellas, Vassilis Georgoulias, Athanasios Kotsakis, Apostolos Klinakis

免疫

细胞生物学

肺癌

肿瘤细胞

发表日期：2024

文献求助收藏

Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients

前列腺癌患者循环肿瘤细胞 (CTC) 中 CXCR4、JUNB 和 PD-L1 表达的综合分析

期刊:Cells

影响因子:5.1

doi:10.3390/cells13090782

Argyro Roumeliotou, Areti Strati, Foteini Chamchougia, Anastasia Xagara, Victoria Tserpeli, Stavroula Smilkou, Elina Lagopodi, Athina Christopoulou, Emmanouil Kontopodis, Ioannis Drositis, Nikolaos Androulakis, Vassilis Georgoulias, Filippos Koinis, Athanasios Kotsakis, Evi Lianidou, Galatea Kallerg

ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment

具有 PD-L1+ CTC 和循环中 CD8+PD-1+T 细胞百分比高的 ES-SCLC 患者可从一线免疫疗法治疗中获益

期刊:Biomedicines

影响因子:3.9

doi:10.3390/biomedicines12010146

Anastasia Xagara, Argyro Roumeliotou, Alexandros Kokkalis, Konstantinos Tsapakidis, Dimitris Papakonstantinou, Vassilis Papadopoulos, Ioannis Samaras, Evagelia Chantzara, Galatea Kallergi, Athanasios Kotsakis

Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients

预先存在的免疫力可预测非小细胞肺癌患者对一线免疫疗法的反应

期刊:Cancers

影响因子:

doi:10.3390/cancers16132393

Anastasia Xagara, Maria Goulielmaki, Sotirios P Fortis, Alexandros Kokkalis, Evangelia Chantzara, George Christodoulopoulos, Ioannis Samaras, Emmanouil Saloustros, Konstantinos Tsapakidis, Vasileios Papadopoulos, Ioannis S Pateras, Vasilis Georgoulias, Constantin N Baxevanis, Athanasios Kotsakis

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology

使用 TetherChip 技术对三阴性乳腺癌患者的活循环肿瘤细胞进行功能分析

期刊:Cells

影响因子:5.1

doi:10.3390/cells12151940

Vasileios Vardas, Julia A Ju, Athina Christopoulou, Anastasia Xagara, Vassilis Georgoulias, Athanasios Kotsakis, Catherine Alix-Panabières, Stuart S Martin, Galatea Kallergi

Missed Coronary Artery Dissection Post-Blunt Chest Trauma

钝性胸部创伤后漏诊冠状动脉夹层

期刊:Cureus Journal of Medical Science

影响因子:1.3

doi:10.7759/cureus.47630

Delia, Vlad I; Emmanouil, Diamantakis; Theodora, Kotsaki A; Dimitra, Kontogianni; Athanasios, Kotsakis

发表日期：2023

文献求助收藏

Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy

奥希替尼对 EGFR 突变型非小细胞肺癌患者 CTC 和 ctDNA 的影响：液体活检的预后意义

期刊:Cancers

影响因子:

doi:10.3390/cancers14061574

Galatea Kallergi, Emmanouil Kontopodis, Aliki Ntzifa, Núria Jordana-Ariza, Niki Karachaliou, Evangelia Pantazaka, Haris A Charalambous, Amanda Psyrri, Emily Tsaroucha, Ioannis Boukovinas, Anna Koumarianou, Dora Hatzidaki, Evi Lianidou, Vassilis Georgoulias, Rafael Rosell, Athanasios Kotsakis

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients

循环肿瘤细胞中的基因表达揭示了 EMT 和 PD-L1 在 NSCLC 患者接受奥希替尼治疗期间的动态作用

期刊:Scientific Reports

影响因子:3.8

doi:10.1038/s41598-021-82068-9

Aliki Ntzifa, Areti Strati, Galatea Kallergi, Athanasios Kotsakis, Vassilis Georgoulias, Evi Lianidou

Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients

治疗前血浆中的小细胞外囊泡可预测非小细胞肺癌患者的临床结果

期刊:Cancers

影响因子:

doi:10.3390/cancers13092041

Eleni-Kyriaki Vetsika, Priyanka Sharma, Ioannis Samaras, Alexandra Markou, Vassilis Georgoulias, Theresa L Whiteside, Athanasios Kotsakis

Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC

hTERT 特异性癌症疫苗 (Vx-001) 在“免疫沙漠” NSCLC 中的临床活性

期刊:Cancers

影响因子:

doi:10.3390/cancers13071658

Ioannis S Pateras, Athanasios Kotsakis, Margaritis Avgeris, Evangelia Baliou, Panagiotis Kouroupakis, Eleni Patsea, Vassilis Georgoulias, Jeanne Menez-Jamet, Jean-Pierre Kinet, Kostas Kosmatopoulos

肿瘤

发表日期：2021

文献求助收藏

Genomic scarring score predicts the response to PARP inhibitors in non-small cell lung cancer

基因组瘢痕评分可预测非小细胞肺癌对 PARP 抑制剂的反应

Comprehensive Analysis of CXCR4, JUNB, and PD-L1 Expression in Circulating Tumor Cells (CTCs) from Prostate Cancer Patients

前列腺癌患者循环肿瘤细胞 (CTC) 中 CXCR4、JUNB 和 PD-L1 表达的综合分析

ES-SCLC Patients with PD-L1+ CTCs and High Percentages of CD8+PD-1+T Cells in Circulation Benefit from Front-Line Immunotherapy Treatment

具有 PD-L1+ CTC 和循环中 CD8+PD-1+T 细胞百分比高的 ES-SCLC 患者可从一线免疫疗法治疗中获益

Pre-Existing Immunity Predicts Response to First-Line Immunotherapy in Non-Small Cell Lung Cancer Patients

预先存在的免疫力可预测非小细胞肺癌患者对一线免疫疗法的反应

Functional Analysis of Viable Circulating Tumor Cells from Triple-Negative Breast Cancer Patients Using TetherChip Technology

使用 TetherChip 技术对三阴性乳腺癌患者的活循环肿瘤细胞进行功能分析

Missed Coronary Artery Dissection Post-Blunt Chest Trauma

钝性胸部创伤后漏诊冠状动脉夹层

Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid Biopsy

奥希替尼对 EGFR 突变型非小细胞肺癌患者 CTC 和 ctDNA 的影响：液体活检的预后意义

Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients

循环肿瘤细胞中的基因表达揭示了 EMT 和 PD-L1 在 NSCLC 患者接受奥希替尼治疗期间的动态作用

Small Extracellular Vesicles in Pre-Therapy Plasma Predict Clinical Outcome in Non-Small-Cell Lung Cancer Patients

治疗前血浆中的小细胞外囊泡可预测非小细胞肺癌患者的临床结果

Clinical Activity of an hTERT-Specific Cancer Vaccine (Vx-001) in "Immune Desert" NSCLC

hTERT 特异性癌症疫苗 (Vx-001) 在“免疫沙漠” NSCLC 中的临床活性